AFDN and leukemia: Based on the C-terminal peptide sequence from one of the ligands for the human AF6 (ALL1-fused gene from chromosome 6) PDZ domain, for example, high-affinity small compounds have been produced that inhibit AF6-Bcr interactions and interfere with growth factor signaling in leukemia cells [75].